Receptor T-Cell Chimeric Antigen Approach Used for the Prediction Model Treatment for Relapsed/Refractory Multiple Myeloma - KIVIRID

Receptor T-Cell Chimeric Antigen Approach Used for the Prediction Model Treatment for Relapsed/Refractory Multiple Myeloma

Authors: Zhao Yin, Qing Zhang, Ruiming Ou, Shuang Liu

Published: 2024-06-24

DOI: 10.1200/jco.24.00544

Source: Full article

Abstract

No abstract found.